Axsome Therapeutics (AXSM) P/E (2016 - 2026)
Axsome Therapeutics (AXSM) P/E from Mar 31, 2016 to Jul 22, 2026. The TTM Axsome Therapeutics (AXSM) P/E is -64.44. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Axsome Therapeutics (AXSM)
| Year | P/E | Change |
|---|---|---|
| 2026 | -64.44 | +29.50% |
| 2025 | -49.76 | +251.30% |
| 2024 | -14.17 | -21.38% |
| 2023 | -18.02 | -6.84% |
| 2022 | -19.34 | +77.14% |
| 2021 | -10.92 | -62.99% |
| 2020 | -29.50 | -44.44% |
| 2019 | -53.09 | +2038.05% |
| 2018 | -2.48 | -42.94% |
| 2017 | -4.35 | -33.11% |
| 2016 | -6.51 | N/A |
Comparison Axsome Therapeutics (AXSM) P/E with competitors
Axsome Therapeutics (AXSM) P/E is -64.44.